SRC and neoplasm: Cytokines like IL-6 and IL-1β enhance the expression of αvβ3 and α5β1 integrins on tumor cells, while integrin engagement activates the FAK/Src, MAPK/ERK, and PI3K/AKT pathways, promoting cancer cell survival, migration, and resistance to therapy [43].